FDA.reportPublic FDA data

aspirin 845 MG / caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011]

RxCUI
1053327
RxNorm name
aspirin 845 MG / caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011]
Display name
STANBACK HEADACHE POWDER REFORMULATED JAN 2011 (Oral Powder)
Full name
aspirin 845 MG / caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011]
Term type
SBD
Status
Active
Strength
845-65 mg
Dose form
Pwdr
Route
Oral Powder
Updated
2026-07-15 00:12:19

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022011
Active start
022011
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
aspirin845 MG / 1 EACHaspirinaspirin
caffeine65 MG / 1 EACHcaffeinecaffeine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Powder346289

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
aspirin1191
caffeine1886

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRASA 845 MG / Caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011]NAMES
RxNorm Nameaspirin 845 MG / caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011]NAMES
RxNorm SynonymASA 845 MG / Caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011]NAMES
RxNorm SynonymStanback Headache Powder Reformulated Jan 2011 (ASA 845 MG / caffeine 65 MG) Oral PowderNAMES
TTYSBDATTRIBUTES
SPL_SET_IDcaaa1313-09e4-45aa-8836-346f6a370196CODES
RxCUI1053327CODES
MMSL_CODEBD27327CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
63029-501-0163029-501Stanback Aspirin and CaffeineMedtech Products Inc.M013
63029-501-0263029-501Stanback Aspirin and CaffeineMedtech Products Inc.M013
63029-501-0663029-501Stanback Aspirin and CaffeineMedtech Products Inc.M013

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M01363029-501Stanback Aspirin and CaffeineOTC MONOGRAPH DRUGMedtech Products Inc.

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
42037010362rxnav_ndcsyes
42037011105rxnav_ndcsyes
42037011107rxnav_ndcsyes
63029050101rxnav_ndcsyes
63029050102rxnav_ndcsyes
63029050106rxnav_ndcsyes
63029050124rxnav_ndcsyes
00135049902rxnav_historical
00135049906rxnav_historical
00135049924rxnav_historical
00135049950rxnav_historical
11530000227rxnav_historical
11530000245rxnav_historical
11530007020rxnav_historical
11530007035rxnav_historical
42037010361rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
caaa1313-09e4-45aa-8836-346f6a370196ASA 845 MG / Caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011]SY12Stanback20250117
caaa1313-09e4-45aa-8836-346f6a370196aspirin 845 MG / caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011]SBD12Stanback20250117
caaa1313-09e4-45aa-8836-346f6a370196STANBACK Headache Powder 845 MG / 65 MG Oral Powder, Reformulated Jan 2011PSN12Stanback20250117
caaa1313-09e4-45aa-8836-346f6a370196Stanback Headache Powder Reformulated Jan 2011 (ASA 845 MG / caffeine 65 MG) Oral PowderSY12Stanback20250117

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
caaa1313-09e4-45aa-8836-346f6a370196StanbackMedtech Products Inc.20250117

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA01ADOther agents for local oral treatmentATC1-4aspirin
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCB01ACPlatelet aggregation inhibitors excl. heparinATC1-4aspirin
ATCN02BASalicylic acid and derivativesATC1-4aspirin
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175722Nonsteroidal Anti-inflammatory DrugEPChas_epcaspirin
FDASPLN0000175578Platelet Aggregation InhibitorEPChas_epcaspirin
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD001241AspirinCHEMhas_ingredientaspirin
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treataspirin
MEDRTD001778Blood Coagulation DisordersDISEASEci_withaspirin
MEDRTD001791Blood Platelet DisordersDISEASEci_withaspirin
MEDRTD002544Cerebral InfarctionDISEASEmay_preventaspirin
MEDRTD002644ChickenpoxDISEASEci_withaspirin
MEDRTD002675Child, PreschoolDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD005334FeverDISEASEmay_treataspirin
MEDRTD006073GoutDISEASEmay_treataspirin
MEDRTD006396HematemesisDISEASEci_withaspirin
MEDRTD006474Hemorrhagic DisordersDISEASEci_withaspirin
MEDRTD007223InfantDISEASEci_withaspirin
MEDRTD007249InflammationDISEASEmay_treataspirin
MEDRTD002546Ischemic Attack, TransientDISEASEmay_preventaspirin
MEDRTD008551MelenaDISEASEci_withaspirin
MEDRTD009203Myocardial InfarctionDISEASEmay_preventaspirin
MEDRTD009298Nasal PolypsDISEASEci_withaspirin
MEDRTD010003OsteoarthritisDISEASEmay_treataspirin
MEDRTD010146PainDISEASEmay_preventaspirin
MEDRTD010146PainDISEASEmay_treataspirin
MEDRTD011225Pre-EclampsiaDISEASEmay_preventaspirin
MEDRTD011263Pregnancy Trimester, ThirdDISEASEci_withaspirin
MEDRTD012213Rheumatic FeverDISEASEmay_treataspirin
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moaaspirin
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008831Decreased Platelet Activating Factor ProductionPEhas_peaspirin
MEDRTN0000008832Decreased Platelet AggregationPEhas_peaspirin
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peaspirin
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_peaspirin
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine
MEDRTN0000000026Hepatic MetabolismPKhas_pkaspirin
MEDRTN0000000042Renal ExcretionPKhas_pkaspirin

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH845 MG / 65 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD27327
CODESRxCUI1053327
CODESSPL_SET_IDcaaa1313-09e4-45aa-8836-346f6a370196
NAMESPrescribable SynonymSTANBACK Headache Powder 845 MG / 65 MG Oral Powder, Reformulated Jan 2011
NAMESRXNAV_STRASA 845 MG / Caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011]
NAMESRxNorm Nameaspirin 845 MG / caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011]
NAMESRxNorm SynonymASA 845 MG / Caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011]
NAMESRxNorm SynonymStanback Headache Powder Reformulated Jan 2011 (ASA 845 MG / caffeine 65 MG) Oral Powder
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK